Weekly Tech+Bio #80: Organoids on Artemis II

Anthropic's $400M AI biotech acqui-hire, CRO stocks reprice, new EMA draft, and pharma's spring acquisition spree

Anthropic pays $400M for a 10-person biotech AI startup, pharma signs $25.5B in acquisitions over eight days, CRO stocks drop on the possibility that AI unbundles the intelligence layer from the execution layer, and bone marrow organoids are heading to the Moon.